Logo image of ADUS

ADDUS HOMECARE CORP (ADUS) Stock Fundamental Analysis

NASDAQ:ADUS - Nasdaq - US0067391062 - Common Stock - Currency: USD

109.23  -2.84 (-2.53%)

After market: 109.23 0 (0%)

Fundamental Rating

7

Taking everything into account, ADUS scores 7 out of 10 in our fundamental rating. ADUS was compared to 108 industry peers in the Health Care Providers & Services industry. ADUS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ADUS is growing strongly while it is still valued neutral. This is a good combination! This makes ADUS very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

ADUS had positive earnings in the past year.
In the past year ADUS had a positive cash flow from operations.
Each year in the past 5 years ADUS has been profitable.
In the past 5 years ADUS always reported a positive cash flow from operatings.
ADUS Yearly Net Income VS EBIT VS OCF VS FCFADUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 6.39%, ADUS belongs to the top of the industry, outperforming 87.85% of the companies in the same industry.
Looking at the Return On Equity, with a value of 7.77%, ADUS is in the better half of the industry, outperforming 71.03% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.89%, ADUS is in the better half of the industry, outperforming 75.70% of the companies in the same industry.
ADUS had an Average Return On Invested Capital over the past 3 years of 7.41%. This is in line with the industry average of 8.14%.
The last Return On Invested Capital (7.89%) for ADUS is above the 3 year average (7.41%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.39%
ROE 7.77%
ROIC 7.89%
ROA(3y)5.26%
ROA(5y)4.69%
ROE(3y)7.99%
ROE(5y)7.13%
ROIC(3y)7.41%
ROIC(5y)6.45%
ADUS Yearly ROA, ROE, ROICADUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8

1.3 Margins

ADUS has a better Profit Margin (6.50%) than 84.11% of its industry peers.
In the last couple of years the Profit Margin of ADUS has grown nicely.
Looking at the Operating Margin, with a value of 9.03%, ADUS belongs to the top of the industry, outperforming 82.24% of the companies in the same industry.
In the last couple of years the Operating Margin of ADUS has grown nicely.
With a Gross Margin value of 32.15%, ADUS perfoms like the industry average, outperforming 57.94% of the companies in the same industry.
ADUS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.03%
PM (TTM) 6.5%
GM 32.15%
OM growth 3Y9.99%
OM growth 5Y14.67%
PM growth 3Y10.91%
PM growth 5Y13.22%
GM growth 3Y3.16%
GM growth 5Y4.03%
ADUS Yearly Profit, Operating, Gross MarginsADUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

More info and screens

8

2. Health

2.1 Basic Checks

ADUS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ADUS has been increased compared to 1 year ago.
ADUS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ADUS has an improved debt to assets ratio.
ADUS Yearly Shares OutstandingADUS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
ADUS Yearly Total Debt VS Total AssetsADUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 7.83 indicates that ADUS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.83, ADUS belongs to the top of the industry, outperforming 92.52% of the companies in the same industry.
ADUS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.83
ROIC/WACC0.89
WACC8.88%
ADUS Yearly LT Debt VS Equity VS FCFADUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

ADUS has a Current Ratio of 2.11. This indicates that ADUS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.11, ADUS is in the better half of the industry, outperforming 71.96% of the companies in the same industry.
A Quick Ratio of 2.11 indicates that ADUS has no problem at all paying its short term obligations.
The Quick ratio of ADUS (2.11) is better than 73.83% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 2.11
ADUS Yearly Current Assets VS Current LiabilitesADUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.47% over the past year.
The Earnings Per Share has been growing by 18.26% on average over the past years. This is quite good.
ADUS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.15%.
Measured over the past years, ADUS shows a quite strong growth in Revenue. The Revenue has been growing by 15.43% on average per year.
EPS 1Y (TTM)20.47%
EPS 3Y13.56%
EPS 5Y18.26%
EPS Q2Q%13.04%
Revenue 1Y (TTM)10.15%
Revenue growth 3Y11.45%
Revenue growth 5Y15.43%
Sales Q2Q%7.04%

3.2 Future

ADUS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.97% yearly.
ADUS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.31% yearly.
EPS Next Y16.38%
EPS Next 2Y15.91%
EPS Next 3Y15.11%
EPS Next 5Y13.97%
Revenue Next Year8.72%
Revenue Next 2Y16.38%
Revenue Next 3Y12.97%
Revenue Next 5Y12.31%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ADUS Yearly Revenue VS EstimatesADUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
ADUS Yearly EPS VS EstimatesADUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 21.09, ADUS is valued on the expensive side.
Based on the Price/Earnings ratio, ADUS is valued a bit cheaper than 68.22% of the companies in the same industry.
ADUS is valuated rather cheaply when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 18.03, which indicates a rather expensive current valuation of ADUS.
67.29% of the companies in the same industry are more expensive than ADUS, based on the Price/Forward Earnings ratio.
ADUS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.09
Fwd PE 18.03
ADUS Price Earnings VS Forward Price EarningsADUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

ADUS's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ADUS indicates a rather cheap valuation: ADUS is cheaper than 81.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.67
EV/EBITDA 15.55
ADUS Per share dataADUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

ADUS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of ADUS may justify a higher PE ratio.
A more expensive valuation may be justified as ADUS's earnings are expected to grow with 15.11% in the coming years.
PEG (NY)1.29
PEG (5Y)1.15
EPS Next 2Y15.91%
EPS Next 3Y15.11%

More info and screens

0

5. Dividend

5.1 Amount

ADUS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ADDUS HOMECARE CORP

NASDAQ:ADUS (2/21/2025, 8:00:04 PM)

After market: 109.23 0 (0%)

109.23

-2.84 (-2.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)02-24 2025-02-24/amc
Inst Owners103.89%
Inst Owner Change3.31%
Ins Owners1.73%
Ins Owner Change0.67%
Market Cap1.98B
Analysts84.44
Price Target143.64 (31.5%)
Short Float %2.81%
Short Ratio3.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.16%
Min EPS beat(2)-0.68%
Max EPS beat(2)9%
EPS beat(4)3
Avg EPS beat(4)6.88%
Min EPS beat(4)-0.68%
Max EPS beat(4)10.37%
EPS beat(8)7
Avg EPS beat(8)7.29%
EPS beat(12)10
Avg EPS beat(12)5.22%
EPS beat(16)11
Avg EPS beat(16)4.27%
Revenue beat(2)0
Avg Revenue beat(2)-1.57%
Min Revenue beat(2)-1.83%
Max Revenue beat(2)-1.3%
Revenue beat(4)0
Avg Revenue beat(4)-1.49%
Min Revenue beat(4)-1.83%
Max Revenue beat(4)-1.28%
Revenue beat(8)0
Avg Revenue beat(8)-1.26%
Revenue beat(12)0
Avg Revenue beat(12)-1.69%
Revenue beat(16)0
Avg Revenue beat(16)-2.15%
PT rev (1m)0.85%
PT rev (3m)2.56%
EPS NQ rev (1m)0.35%
EPS NQ rev (3m)-0.61%
EPS NY rev (1m)0.13%
EPS NY rev (3m)-1.5%
Revenue NQ rev (1m)5.07%
Revenue NQ rev (3m)4.28%
Revenue NY rev (1m)0.34%
Revenue NY rev (3m)1.03%
Valuation
Industry RankSector Rank
PE 21.09
Fwd PE 18.03
P/S 1.75
P/FCF 15.67
P/OCF 14.55
P/B 2.09
P/tB 10.03
EV/EBITDA 15.55
EPS(TTM)5.18
EY4.74%
EPS(NY)6.06
Fwd EY5.55%
FCF(TTM)6.97
FCFY6.38%
OCF(TTM)7.5
OCFY6.87%
SpS62.54
BVpS52.27
TBVpS10.89
PEG (NY)1.29
PEG (5Y)1.15
Profitability
Industry RankSector Rank
ROA 6.39%
ROE 7.77%
ROCE 10.29%
ROIC 7.89%
ROICexc 10.16%
ROICexgc 356.56%
OM 9.03%
PM (TTM) 6.5%
GM 32.15%
FCFM 11.15%
ROA(3y)5.26%
ROA(5y)4.69%
ROE(3y)7.99%
ROE(5y)7.13%
ROIC(3y)7.41%
ROIC(5y)6.45%
ROICexc(3y)8.47%
ROICexc(5y)7.58%
ROICexgc(3y)87.71%
ROICexgc(5y)69.95%
ROCE(3y)9.67%
ROCE(5y)8.41%
ROICexcg growth 3Y24.91%
ROICexcg growth 5Y31.22%
ROICexc growth 3Y10.93%
ROICexc growth 5Y1.53%
OM growth 3Y9.99%
OM growth 5Y14.67%
PM growth 3Y10.91%
PM growth 5Y13.22%
GM growth 3Y3.16%
GM growth 5Y4.03%
F-Score7
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 69.13%
Cap/Sales 0.85%
Interest Coverage 13.31
Cash Conversion 116.95%
Profit Quality 171.61%
Current Ratio 2.11
Quick Ratio 2.11
Altman-Z 7.83
F-Score7
WACC8.88%
ROIC/WACC0.89
Cap/Depr(3y)52.67%
Cap/Depr(5y)51.52%
Cap/Sales(3y)0.77%
Cap/Sales(5y)0.78%
Profit Quality(3y)150.66%
Profit Quality(5y)158.26%
High Growth Momentum
Growth
EPS 1Y (TTM)20.47%
EPS 3Y13.56%
EPS 5Y18.26%
EPS Q2Q%13.04%
EPS Next Y16.38%
EPS Next 2Y15.91%
EPS Next 3Y15.11%
EPS Next 5Y13.97%
Revenue 1Y (TTM)10.15%
Revenue growth 3Y11.45%
Revenue growth 5Y15.43%
Sales Q2Q%7.04%
Revenue Next Year8.72%
Revenue Next 2Y16.38%
Revenue Next 3Y12.97%
Revenue Next 5Y12.31%
EBIT growth 1Y17.51%
EBIT growth 3Y22.58%
EBIT growth 5Y32.37%
EBIT Next Year39.36%
EBIT Next 3Y24.01%
EBIT Next 5Y19.41%
FCF growth 1Y24.25%
FCF growth 3Y0.06%
FCF growth 5Y29.8%
OCF growth 1Y28.34%
OCF growth 3Y0.86%
OCF growth 5Y27.59%